This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CNGB3 Gene Therapy (Athena)

Athena Vision

Drug Names(s): CNGB3 gene therapy,

Description: Athena Vision is developing an adenovirus associated viral vector serotype 8 containing the human CNGB3 gene for the treatment of achromatopsia.

CNGB3 Gene Therapy (Athena) News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug